Has Douglas Drachman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $132,349 in general payments to Douglas Drachman, MD across 103 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Douglas Drachman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Douglas Drachman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Douglas Drachman, MD

Interventional Cardiology · Boston, MANPI 1245211176

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $109,543 of the $132,349 with a category attached, or 82.8%. Cardiovascular Systems Inc. accounts for 72.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $41,037 and has fallen 88.2% since, to $4,849 in 2025. Among interventional cardiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$132,349in general payments, 2019–2025

Across 103 payments — averaging $1284.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cardiovascular Systems Inc.$95K
Abbott$21K
Pfizer$6K
Boston Scientific$5K
Shockwave Medical, Inc$3K
Abiomed$1K
plus $2K from 7 others

$3,600in research payments, 2019–2025

Across 2 payments — averaging $1800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Atrium Medical Corporation$4K

What the payments were for

Consulting fees$109,54383%
Speaking & faculty fees$17,12513%
Travel & lodging$3,2432%
Food & beverage$2,4382%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cardiovascular Systems Inc.	46	$95,258
Abbott	28	$20,542
Pfizer	13	$5,635
Boston Scientific	4	$4,590
Shockwave Medical, Inc	2	$3,229
Abiomed	2	$1,348
Cardinal Health 200 LLC	1	$1,100
Penumbra, Inc.	1	$159
Chiesi USA, Inc.	1	$133
Cordis US CORP.	1	$123
Edwards Lifesciences	1	$107
Spectrawave, Inc	2	$78
Medtronic	1	$47

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Coronary Orbital Atherectomy System$52,786
Diamondback Coronary$26,810
Diamondback Peripheral$18,697
Omnilink Elite vascular stent system$16,027
GENERAL - THERAPIES$4,000
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$3,229
Peripheral Orbital Atherectomy System$393
GENERAL VASCULAR ACCESS$375
Indigo System$159
CROSSBOSS$157
DRAGONFLY OPSTAR$149
KENGREAL$133
Supera peripheral stent system$126
SELUTION SLRPTA$123
COROFLOW$115

How this compares

$132,349 in reported general payments places this provider in the 90th percentile of 128 interventional cardiology providers in Massachusetts.

See all interventional cardiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$166,896

Medicare patients

471

Services billed

1,478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	12	$131
Metoprolol Succinate	11	$111

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Boston

Eric SecemskyBoston$1.2M
Darshan DoshiBoston$730K
Charles GibsonBoston$661K
Duane PintoBoston$491K
Robert YehBoston$412K
Suzanne BaronBoston$274K
Farouc JafferBoston$213K
Joseph GarasicBoston$152K
Pinak ShahBoston$147K
Hector Tamez AguilarBoston$123K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →